Advocacy

Virginia: SB 274

The Virginia legislature has passed a bill to establish a Prescription Drug Affordability Board, and Governor Youngkin needs to hear from you!

Here are some details about SB 274:

• Does not include any mechanism to make sure potential savings achieved from by PDAB actions actually decrease out of pocket costs for patients.
• Threatens access to treatments through the implementation of an upper payment limit (UPL).
• Does not take a holistic look at all cost drivers in the prescription drug pipeline.
• Tasks the board to lower drug prices, not improve patient care.
• Does not require a health care provider to serve on the Board.
• Relegates patient perspectives to a secondary advisory panel with no decision-making authority.
• Does not ensure discriminatory metrics like the QALY will not be used at any point in the selection, assessment or UPL-setting processes by the Board.
• Does not provide direct accountability for Board decisions to the citizens of Virginia.

Action Alert

The Value of Care Coalition urges stakeholders to submit a letter directly to the Governor asking him to consider value as defined by patients and providers on the front lines of health care and VETO SB 274.

To submit a letter from your organization, please email to:

The Honorable Glenn Youngkin
Governor of Virginia
1111 East Broad Street
Richmond, VA 23219
Glenn.youngkin@governor.virginia.gov

Please CC to:

Ali Ahmed
Director of Policy and Legislative Affairs
Office of the Governor
1111 East Broad Street
Richmond, VA 23219
Ali.ahmed@governor.virginia.gov

Hallie Pence
Deputy Policy Director
Office of the Governor
1111 East Broad Street
Richmond, VA 23219
Hallie.pence@governor.virginia.gov